CONMED | CNMD - Equity Capital And Reserves



CONMED reported $932.9M in Equity Capital and Reserves for its fiscal quarter ending in September of 2024.

Equity Capital And Reserves Change Date
3M USD 4.64B 654M Sep/2024
Abbott USD 39.56B 0 Sep/2024
AtriCure USD 465.02M 2.94M Sep/2024
Avanos Medical USD 1.23B 7.7M Sep/2024
Baxter International USD 7.71B 0 Sep/2024
Becton, Dickinson and Co. USD 25.91B 43M Sep/2024
Boston Scientific USD 20.71B 540M Sep/2024
CONMED USD 932.9M 51.07M Sep/2024
Cooper Companies USD 7.93B 121.3M Jul/2024
Dexcom USD 1.98B 455.3M Sep/2024
Edwards Lifesciences USD 7.5B 0 Sep/2024
Globus Medical USD 4.07B 93.03M Sep/2024
Hologic USD 5.13B 179.1M Sep/2024
Insulet USD 1.12B 119.6M Sep/2024
Integra LifeSciences USD 1.52B 12.61M Sep/2024
Intuitive Surgical USD 15.58B 786.8M Sep/2024
J&J USD 71.54B 0 Sep/2024
Masimo USD 1.46B 94.4M Sep/2024
Medtronic USD 48.16B 2.26B Jun/2024
Merit Medical Systems USD 1.32B 40.97M Sep/2024
Olympus JPY 703.09B 86.97B Sep/2024
ResMed USD 5.2B 330.99M Sep/2024
Smith & Nephew USD 5.2B 12M Jun/2024
Steris USD 6.59B 223.05M Sep/2024
Stryker USD 20.15B 387M Sep/2024
Tandem Diabetes Care USD 237.71M 3.83M Sep/2024
Teleflex USD 4.48B 3K Oct/2024
Zimmer Biomet Holdings USD 12.37B 366.4M Sep/2024